At diagnosis, FLT3-ITD mutations were more frequent in patients with NPM1-mut at relapse, while DNMT3A mutations were more frequent in those relapsing with NPM1-WT AML [34]. The gene discussed is NPM1; the disease is acute myeloid leukemia.